Safety, immunology, and biological activity evaluation of TroVax in treatment of patients with locally advanced or metastatic renal carcinoma
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2008
At a glance
- Drugs Interleukin-2; MVA 5T4
- Indications Renal cancer
- Focus Therapeutic Use
- Sponsors Oxford BioMedica
- 31 Aug 2018 Biomarkers information updated
- 31 Jul 2008 The actual completion date for this trial was 1 July 2008.
- 31 Jul 2008 Status changed from in progress to completed according to clinicaltrials.gov record.